DK2999478T3 - Dextransulfat til anvendelse ved mobilisering af celler - Google Patents

Dextransulfat til anvendelse ved mobilisering af celler Download PDF

Info

Publication number
DK2999478T3
DK2999478T3 DK14797927.2T DK14797927T DK2999478T3 DK 2999478 T3 DK2999478 T3 DK 2999478T3 DK 14797927 T DK14797927 T DK 14797927T DK 2999478 T3 DK2999478 T3 DK 2999478T3
Authority
DK
Denmark
Prior art keywords
dextransulphate
cell mobilization
mobilization
cell
Prior art date
Application number
DK14797927.2T
Other languages
English (en)
Inventor
Anders Waas
Ida Duprez
Original Assignee
Tx Medic Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tx Medic Ab filed Critical Tx Medic Ab
Application granted granted Critical
Publication of DK2999478T3 publication Critical patent/DK2999478T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK14797927.2T 2013-05-13 2014-05-12 Dextransulfat til anvendelse ved mobilisering af celler DK2999478T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1350584A SE537742C2 (sv) 2013-05-13 2013-05-13 Dextransulfat för cellmobilisering
PCT/SE2014/050576 WO2014185851A1 (en) 2013-05-13 2014-05-12 Dextran sulfate for use in mobilization of cells

Publications (1)

Publication Number Publication Date
DK2999478T3 true DK2999478T3 (da) 2020-04-14

Family

ID=51898693

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14797927.2T DK2999478T3 (da) 2013-05-13 2014-05-12 Dextransulfat til anvendelse ved mobilisering af celler

Country Status (10)

Country Link
US (1) US10258642B2 (da)
EP (1) EP2999478B1 (da)
JP (1) JP6339668B2 (da)
CN (1) CN105358159B (da)
CA (1) CA2912366C (da)
DK (1) DK2999478T3 (da)
ES (1) ES2780907T3 (da)
PL (1) PL2999478T3 (da)
SE (1) SE537742C2 (da)
WO (1) WO2014185851A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201408233D0 (en) 2014-05-09 2014-06-25 Austrianova Singapore Pte Ltd Use of polyanionic composition
SE538503C2 (en) * 2014-11-11 2016-08-16 Tx Medic Ab New dextran sulfate
RU2623152C9 (ru) * 2015-10-15 2022-02-17 Акционерное общество "Федеральный научно-производственный центр "Алтай" Композиция, обладающая гепатопротекторными и иммуностимулирующими свойствами
CN114127262A (zh) * 2019-05-16 2022-03-01 香港中文大学 细胞外基质材料及其用途
SE544015C2 (en) * 2019-06-18 2021-11-02 Tx Medic Ab Allogenic car-t cell therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3454560A (en) 1966-03-01 1969-07-08 Seikagaku Kogyo Co Ltd Process for the production of chondroitin polysulfate
SE525461C3 (sv) 2002-11-28 2005-03-23 Prophymed Ab Ny användning av dextransulfat
CN1589904A (zh) 2003-09-01 2005-03-09 北京大学 造血干细胞动员剂制备治疗糖尿病药物的用途

Also Published As

Publication number Publication date
JP6339668B2 (ja) 2018-06-06
CA2912366A1 (en) 2014-11-20
ES2780907T3 (es) 2020-08-27
CN105358159B (zh) 2018-08-28
BR112015028270A2 (pt) 2017-07-25
PL2999478T3 (pl) 2020-10-19
EP2999478B1 (en) 2020-01-15
SE537742C2 (sv) 2015-10-13
CA2912366C (en) 2021-04-06
US10258642B2 (en) 2019-04-16
EP2999478A1 (en) 2016-03-30
US20160120897A1 (en) 2016-05-05
SE1350584A1 (sv) 2014-11-14
CN105358159A (zh) 2016-02-24
WO2014185851A1 (en) 2014-11-20
JP2016519143A (ja) 2016-06-30
EP2999478A4 (en) 2017-02-22

Similar Documents

Publication Publication Date Title
IL245573B (en) Cell
DK3013964T3 (da) Sammensætninger til indføring af rna i celler
DK3017520T3 (da) Solcelleanordning
DK2762509T3 (da) Sammensætning til anvendelse ved fremstilling af polyurethansystemer
DK2978419T3 (da) Sammensætninger til forbedring af cellelevedygtighed og fremgangsmåder til anvendelse deraf
DK3537097T3 (da) Indretning til udformning af riller i rørelementer
DK2953634T3 (da) Fremgangsmåder til udvidelse eller udtømning af regulerende t-celler
DK3042411T3 (da) Metalunderstøttet fastoxidbrændselscelle
DK3014641T3 (da) Biokemisk energiomdannelsescelle
DE112014004775T8 (de) Zellenmodul-Anordnungen
DK2941483T3 (da) Fremgangsmåde til at opnå immunstimulerende dendritriske celler
EP2972772A4 (en) ON-SITE SNAPSHOTS
DK3351645T3 (da) Pyrofosforolytisk sekventering ved anvendelse af nanoporer
BR302012004517S1 (pt) Configuracao aplicada em estojo
DK3079658T3 (da) Kammer til indkapsling af secernerende celler
BR302013002629S1 (pt) Configuração aplicada em estojo
BR302013000344S1 (pt) Configuração aplicação em telefone celular
EP3011599C0 (en) PHOTOVOLTAIC DEVICES
FR3003076B1 (fr) Supercondensateur electrochimique
DK3071755T3 (da) Energiplatform
DK3003285T3 (en) Fast farmaceutisk dosisform til frigivelse af mindst to aktive farmaceutiske ingredienser i mundhulen
DK2970843T3 (da) Fremgangsmåder til frembringelse af cellebank med høj densitet
IL245762B (en) Combined energy network
DK3234476T3 (da) Solfanger
BR302014002326S1 (pt) Configuração aplicada em bolsa